Dividends Calendar Earnings Calendar
ALVR

ALVR | Allovir Inc

Healthcare sector
Allovir Inc
Category: Healthcare
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 1.54B
  • Prev closed: 19.89
  • Open: 19.86
  • High: 20.3
  • Low: 19.63
  • 52 week low: 16.66
  • 52 week high: 48.96
  • Dividends:No Dividends

Next ER: November 16, 2021 



Top Stories (ALVR)

    Company Profile

    AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company?s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir?s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 10, 2022
    November 16, 2021- / -0.55- / -
    November 5, 2021-0.72 / -0.5509- / -
    September 1, 2021- / -0.4165- / -
    August 6, 2021-0.6 / -0.455- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 22, 2021 19.00 19.72
    19.73
    18.75
    		 88.36K -5.38%
    Nov 19, 2021 20.08 21.49
    21.49
    19.91
    		 162.14K -5.01%
    Nov 18, 2021 21.14 21.20
    21.32
    20.68
    		 139.76K 0.62%
    Nov 17, 2021 21.01 20.99
    21.39
    20.36
    		 135.87K -1.45%
    Nov 16, 2021 21.32 21.76
    21.76
    20.50
    		 147.16K -1.89%
    Nov 15, 2021 21.73 22.35
    22.35
    21.53
    		 108.71K -2.64%
    Nov 12, 2021 22.32 23.27
    23.27
    21.84
    		 122.00K -5.06%
    Nov 11, 2021 23.51 23.94
    24.34
    23.30
    		 81.07K -1.47%
    Nov 10, 2021 23.86 24.20
    24.93
    23.47
    		 141.26K -2.37%
    Nov 9, 2021 24.44 24.08
    24.85
    23.55
    		 93.67K 1.66%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:32

    News

    News for (ALVR)

    This company doesn't provide a dividend.


    Talk about Allovir Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 16, 2021 (Same day)

    wmt clls ntes.ch hd vod armk se tdg stne doyu jmia vrex 


    Jump to (Finance sites)

    Google     
             

    Research 


    Investor page

    ir.allovir.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet